The intricate and complex nature of neurodegenerative diseases have proved a burden for drug developers to create clinically effective therapies for Alzheimer’s, Parkinson’s, Huntington’s, ALS and more. Could a more precise therapeutic approach which integrates genomics, clinical data and carefully considers challenges with moving across the blood brain barrier be the solution? Is a precision neurology approach the next step industry must take to treat neurodegenerative disease once and for all? Attend this workshop to find out.
Time: 8:01 am
day: Pre-Conference Discussion Day